Literature DB >> 15155228

Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan.

Yumiko Sanbongi1, Takashi Ida, Midori Ishikawa, Yumi Osaki, Hiroshi Kataoka, Takahisa Suzuki, Kumiko Kondo, Fukuichi Ohsawa, Minoru Yonezawa.   

Abstract

All six penicillin-binding protein (PBP) genes, namely, pbp1a, pbp1b, pbp2a, pbp2b, pbp2x, and pbp3, of 40 Streptococcus pneumoniae clinical isolates, including penicillin-resistant S. pneumoniae isolates collected in Japan, were completely sequenced. The MICs of penicillin for these strains varied between 0.015 and 8 microg/ml. In PBP 2X, the Thr550Ala mutation close to the KSG motif was observed in only 1 of 40 strains, whereas the Met339Phe mutation in the STMK motif was observed in six strains. These six strains were highly resistant (MICs >/= 2 microg/ml) to cefotaxime. The MICs of cefotaxime for 27 strains bearing the Thr338Ala mutation tended to increase, but the His394Leu mutation next to the SSN motif did not exist in these strains. In PBP 2B, the Thr451Ala/Phe/Ser and Glu481Gly mutations close to the SSN motif were observed in 24 strains, which showed penicillin resistance and intermediate resistance, and the Thr624Gly mutation close to the KTG motif was observed in 2 strains for which the imipenem MIC (0.5 microg/ml) was the highest imipenem MIC detected. In PBP 1A, the Thr371Ser/Ala mutation in the STMK motif was observed in all 13 strains for which the penicillin MICs were >/=1 microg/ml. In PBP 2A, the Thr411Ala mutation in the STIK motif was observed in one strain for which with the cefotaxime MIC (8 microg/ml) was the highest cefotaxime MIC detected. On the other hand, in PBPs 1B and 3, no mutations associated with resistance were observed. The results obtained here support the concept that alterations in PBPs 2B, 2X, and 1A are mainly involved in S. pneumoniae resistance to beta-lactam antibiotics. Our findings also suggest that the Thr411Ala mutation in PBP 2A may be associated with beta-lactam resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155228      PMCID: PMC415593          DOI: 10.1128/AAC.48.6.2244-2250.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  C G Dowson; A Hutchison; J A Brannigan; R C George; D Hansman; J Liñares; A Tomasz; J M Smith; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Directly repeated insertion of 9-nucleotide sequence detected in penicillin-binding protein 2B gene of penicillin-resistant Streptococcus pneumoniae.

Authors:  A Yamane; H Nakano; Y Asahi; K Ubukata; M Konno
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan.

Authors:  Kenji Suzuki; Tadao Nishimura; Shunkichi Baba
Journal:  J Infect Chemother       Date:  2003-03       Impact factor: 2.211

4.  A mutation in the D,D-carboxypeptidase penicillin-binding protein 3 of Streptococcus pneumoniae contributes to cefotaxime resistance of the laboratory mutant C604.

Authors:  J Krauss; R Hakenbeck
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Genetics of high level penicillin resistance in clinical isolates of Streptococcus pneumoniae.

Authors:  V A Barcus; K Ghanekar; M Yeo; T J Coffey; C G Dowson
Journal:  FEMS Microbiol Lett       Date:  1995-03-01       Impact factor: 2.742

6.  Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

7.  Penicillin-binding proteins as resistance determinants in clinical isolates of Streptococcus pneumoniae.

Authors:  P Reichmann; A König; A Marton; R Hakenbeck
Journal:  Microb Drug Resist       Date:  1996       Impact factor: 3.431

8.  Acquisition of five high-Mr penicillin-binding protein variants during transfer of high-level beta-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae.

Authors:  R Hakenbeck; A König; I Kern; M van der Linden; W Keck; D Billot-Klein; R Legrand; B Schoot; L Gutmann
Journal:  J Bacteriol       Date:  1998-04       Impact factor: 3.490

9.  Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics.

Authors:  T Grebe; R Hakenbeck
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins.

Authors:  T J Coffey; M Daniels; L K McDougal; C G Dowson; F C Tenover; B G Spratt
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

View more
  24 in total

1.  Emergence of a unique penicillin-resistant Streptococcus pneumoniae serogroup 35 strain.

Authors:  Ronald J Stanek; Mary B Maher; Nancy B Norton; Maurice A Mufson
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

2.  Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with different levels of beta-lactam resistance.

Authors:  Laurent Chesnel; Raphaël Carapito; Jacques Croizé; Otto Dideberg; Thierry Vernet; André Zapun
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  Contribution of penicillin-binding protein homologs to antibiotic resistance, cell morphology, and virulence of Listeria monocytogenes EGDe.

Authors:  Caitriona M Guinane; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Structural analysis of an "open" form of PBP1B from Streptococcus pneumoniae.

Authors:  Andrew L Lovering; Liza De Castro; Daniel Lim; Natalie C J Strynadka
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

5.  Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae isolates in Taiwan.

Authors:  Cheng-Hsun Chiu; Lin-Hui Su; Yhu-Chering Huang; Jui-Chia Lai; Hsiu-Ling Chen; Tsu-Lan Wu; Tzou-Yien Lin
Journal:  Antimicrob Agents Chemother       Date:  2007-06-25       Impact factor: 5.191

6.  Diversity of penicillin binding proteins among clinical Streptococcus pneumoniae strains from Portugal.

Authors:  Ricardo Dias; David Félix; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

7.  Crystallization and preliminary crystallographic analysis of the transpeptidase domain of penicillin-binding protein 2B from Streptococcus pneumoniae.

Authors:  Mototsugu Yamada; Takashi Watanabe; Nobuyoshi Baba; Takako Miyara; Jun Saito; Yasuo Takeuchi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-03-21

8.  Commensal streptococci serve as a reservoir for β-lactam resistance genes in Streptococcus pneumoniae.

Authors:  Anders Jensen; Oskar Valdórsson; Niels Frimodt-Møller; Susan Hollingshead; Mogens Kilian
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

9.  Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.

Authors:  Klaudia Kosowska-Shick; Pamela McGhee; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2009-02-23       Impact factor: 5.191

10.  An important site in PBP2x of penicillin-resistant clinical isolates of Streptococcus pneumoniae: mutational analysis of Thr338.

Authors:  Ilka Zerfass; Regine Hakenbeck; Dalia Denapaite
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.